Seizure Burden before and after Lidocaine as Add-On Therapy in (Amplitude-Integrated) Electroencephalography-Confirmed Neonatal Seizures
Neonatology · 28.11.2025 · 123 (2) · 145-153
DOI: 10.1159/000549690 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neonatology, online erschienen am 28.11.2025. Verfasst von Mathies Rondagh und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neonatology, Department of Pediatrics, Willem-Alexander Children's Hospital, Leiden University Medical Center, Leiden, The Netherlands, m…. Hauptthemen laut MEDLINE: Seizures, Lidocaine, Anticonvulsants, Anesthetics, Local. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
The primary aim of this study was to evaluate the total seizure burden (TSB) and maximum hourly seizure burden (MSB) before and after the administration of lidocaine (LDC) as add-on therapy in neonates with amplitude-integrated electroencephalography (aEEG)-confirmed seizures. Secondary aims were documenting the need for additional ASM at 4, 12, and 24 h after LDC and the rate of seizure freedom for at least 24, 48, and 72 h after LDC.
Methods
This single-center, retrospective cohort study included neonates with persistent seizures after phenobarbital who received add-on LDC therapy. Neonates were monitored with a continuous 2-channel aEEG. The TSB and MSB were calculated using raw EEG data collected 4 h before and after the administration of LDC.
Results
Sixty-one neonates were included. Seizure etiology consisted of hypoxic-ischemic encephalopathy (n = 24), hemorrhagic or ischemic stroke (n = 16), central nervous system infection (n = 7), genetic (n = 8), metabolic disorders (n = 4), and unknown etiology (n = 2). After LDC administration, median TSB decreased significantly from 31 (interquartile range [IQR] 16–68) to 0 min (IQR 0–0, p < 0.01) and MSB from 10 (IQR 6–41) to 0 min/h (IQR 0–0, p < 0.01). The need for additional ASM was 3% (2/61) within 4 h and 41% (25/61) within 24 h. Seizure freedom after LDC was achieved in 71% (42/59) for at least 24 h and 52% (29/56) for 72 h.
Discussion
LDC significantly reduced TSB and MSB in neonates with (a)EEG-confirmed seizures, achieving 100% seizure reduction in the majority, with half of the neonates remaining seizure-free for at least 72 h.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Neonatology, Department of Pediatrics, Willem-Alexander Children's Hospital, Leiden University Medical Center, Leiden, The Netherlands, m.rondagh@lumc.nl.
- Division of Neonatology, Department of Pediatrics, Willem-Alexander Children's Hospital, Leiden University Medical Center, Leiden, The Netherlands.
- Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.
Zitieren
APA
Rondagh, M., van Oldenmark, B. O., van Steenis, A., Tromp, S. C., Tan, R. N. G. B., Lopriore, E., Steggerda, S. J., & de Vries, L. S. (2025). Seizure Burden before and after Lidocaine as Add-On Therapy in (Amplitude-Integrated) Electroencephalography-Confirmed Neonatal Seizures. Neonatology, 123(2), 145-153. https://doi.org/10.1159/000549690
Vancouver
Rondagh M, van Oldenmark BO, van Steenis A, Tromp SC, Tan RNGB, Lopriore E, et al. Seizure Burden before and after Lidocaine as Add-On Therapy in (Amplitude-Integrated) Electroencephalography-Confirmed Neonatal Seizures. Neonatology. 2025;123(2):145-153. doi:10.1159/000549690
BibTeX
@article{Rondagh2025,
author = {Rondagh, Mathies and van Oldenmark, Bregje O and van Steenis, Andrea and Tromp, Selma C and Tan, Ratna N G B and Lopriore, Enrico and Steggerda, Sylke J and de Vries, Linda S},
title = {Seizure Burden before and after Lidocaine as Add-On Therapy in (Amplitude-Integrated) Electroencephalography-Confirmed Neonatal Seizures},
journal = {Neonatology},
year = {2025},
volume = {123},
number = {2},
pages = {145--153},
doi = {10.1159/000549690}
}
EUVIMED